UK Markets closed
  • NIKKEI 225

    27,968.99
    -58.85 (-0.21%)
     
  • HANG SENG

    18,597.23
    +392.55 (+2.16%)
     
  • CRUDE OIL

    80.44
    +2.24 (+2.86%)
     
  • GOLD FUTURES

    1,770.30
    +6.60 (+0.37%)
     
  • DOW

    33,909.12
    +56.59 (+0.17%)
     
  • BTC-GBP

    14,084.81
    +341.91 (+2.49%)
     
  • CMC Crypto 200

    401.06
    +0.36 (+0.09%)
     
  • Nasdaq

    11,119.06
    +135.28 (+1.23%)
     
  • ^FTAS

    4,139.65
    +27.35 (+0.67%)
     

Convatec Group PLC: Results of 2022 AGM – Update Statement

Convatec Group PLC (CTEC)
Convatec Group PLC: Results of 2022 AGM – Update Statement
23-Sep-2022 / 14:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

23 September 2022

Convatec Group Plc
("Convatec" or "the Company")

Results of 2022 AGM – Update Statement

While the Resolution to approve the Directors' Remuneration Report at the last AGM was passed, we acknowledge that a number of shareholders chose not to support this Resolution.

Prior to the AGM the Remuneration Committee consulted extensively with shareholders and following the AGM, the Remuneration Committee Chair wrote to our largest shareholders who voted against the Resolution to understand their reasons and to offer further engagement.

The Remuneration Committee is committed to positive engagement with shareholders and will be consulting further over the coming months in respect of the Company's forthcoming Remuneration Policy review.

 

 

Enquiries 

Analysts and Investors 

Kate Postans, VP Investor Relations, Convatec                                                            +44 (0)782 644 7807 

ir@convatec.com 

 

Media 

Buchanan: Charles Ryland / Chris Lane                                                                    +44 (0)207 466 5000  

Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92 

 

About Convatec 
 

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a FTSE 250 global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Group revenues in 2021 were over $2 billion. With around 10,000 colleagues, we provide our products and services in over 100 countries, united by a promise to be forever caring. Our products provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. To learn more about Convatec, please visit http://www.convatecgroup.com

 


ISIN:

GB00BD3VFW73

Category Code:

AGM

TIDM:

CTEC

LEI Code:

213800LS272L4FIDOH92

Sequence No.:

189992

EQS News ID:

1448703


 

End of Announcement

EQS News Service

show this
show this